Abstract
Diabetic Retinopathy (DR) affects one-third of patients with type 2 Diabetes (DM2), as the main reversible cause of blindness and loss of quality of life in this population. The development of new retinal assessment techniques, in particular optical coherence tomography to measure the central retinal thickness (CRT), stands out as a non-invasive method for detecting patients with early st…